 Table 1. 
BENCHMARKS
DNA methylation of genes is increasingly recognized as one of the major mechanisms of gene inactivation that may contribute to the development of human cancer by silencing genes that suppress tumor growth (1) . In recent years, methylation-specific PCR (MSP) of bisulfite-modified genomic DNA (gDNA) has been used as a standard method to detect DNA methylation changes at CpG islands (2) . MSP is a PCR-based method that requires much less gDNA than the traditional Southern blot analysis method. However, the MSP assay has to be set up individually for each gene using methylated and unmethylated primer pairs, and the result of the assay is determined by visual interpretation of the MSP products after agarose gel electrophoresis. Consequently, there is no objective cutoff value for MSP, and the determination of methylation changes is not quantitative. Here, we describe the methylation-specific single base extension (MSBE) assay that could detect DNA methylation at one or multiple CpG islands simultaneously in a semiautomatic fashion. This method is easy to set up and is more quantitative than the traditional MSP assay. It is also easily expandable for large, genome-wide screening of promoter-methylation status of many genes by the use of multiple primers.
As shown in Figure 1 , DNA fragments were first amplified using nonmethylation-sensitive primers and sodium bisulfite-modified gDNA (2) . After purification of the PCR product, a single base was extended at the predetermined CpG site with primers that complemented to either the methylated (March 2005) or the unmethylated sequences using the SNaPshot™ kit (Applied Biosystems, Foster City, CA, USA). This kit uses the single base extension (SBE) principle to detect variations of single nucleotide polymorphisms. The extended products were then analyzed on an ABI Prism ® 3100 Genetic Analyzer (Applied Biosystems), and the status of DNA methylation was determined based on the relative peak heights of the extended products generated from methylated and unmethylated templates.
In this report, we used the detection of hypermethylation in the promoter of the tumor-suppressor gene p16 INK4A to demonstrate the MSBE assay method. In general, about 1 μg gDNA was used for the sodium bisulfite treatment (2) . Modified genomic DNA was amplified with p16 INK4A gene-specific primers corresponding to the sodium bisulfitetreated DNA samples as shown in Table  1 . PCR amplification was performed under the following conditions: initial incubation at 95°C for 10 min, then 35 cycles of 95°C for 30 s, 56°C for 30 s, 72°C for 1 min, and a final extension at 72°C for 7 min in a mixture containing 1× PCR Gold™ buffer (Roche, Basel, Switzerland) with 1.5 mM MgCl 2 , 0.2 mM dNTPs, 10 pmol of each primer, and 50-100 ng of bisulfite-treated gDNA. The amplified products (20 μL) were then purified with a QIAquick™ PCR purification kit (Qiagen, Venlo, The Netherlands) and eluted in a final volume of 50 μL.
For the SBE reaction, 5 μL of SNaPshot Ready reaction mix was used with 1 μL purified PCR product and 0.5-2 pmol SBE primers in a total volume of 10 μL. The SBE condition was 30 cycles of 96°C for 10 s, 55°C for 5 s, and 60°C for 30 s. The single baseextended samples were treated with 1 U shrimp alkaline photophatase to remove the unincorporated fluorescent ddNTPs at 37°C for 1 h, followed by inactivation at 75°C for 15 min as suggested by the manufacturer. The resulting 0.5-μL dephosphorylated samples were mixed with 9.4 μL Hi-Di™ formamide and 0.1 μL GeneScan™ 120 LIZ™ marker (both from Applied Biosystems), and analyzed on the automatic sequencer to determine the peak heights for the extended products corresponding to either methylated or unmethylated DNA sequence. The DNA sequences for the methylation sites of interest and primers used in the PCR and the SBE assays are shown in Table 1 . Figure 2 is a plot of the SBE results using various ratios of the cloned p16 INK4A gene fragments (TOPO ® ; Invitrogen, Carlsbad, CA, USA) that matched to either methylated or unmethylated DNA sequences after sodium bisulfite treatment. When these sequence-confirmed fragments were used, the relative ratios of the methylated and unmemthylated peaks were directly linear with the 
relative ratios of the input template plasmids. This result suggests that the peak ratios obtained through MSBE correlated linearly with the fraction of DNA methylation present at the site of interest in the input template sample. However, when this experiment was done using various ratios of gDNA templates that were either fully methylated (lung cancer cell line, H1299) or unmethylated (non-tumor lung) at the p16 INK4A locus prior to sodium bisulfite treatment, the ratio of the peak heights (methylated/unmethylated) was about 40% lower than the ratios obtained from the mixture of plasmid DNA templates. This reduction was most likely caused by the PCR bias on the sodium bisulfitemodified DNA leading to the preferential amplification of unmethylated strands as reported previously (3). Nevertheless, this limitation does not affect the relatively quantitative and semiautomatic nature of the MSBE assay. When 40 non-tumor lung tissues were tested, the ratio of the peaks from methylated and unmethylated template was <0.1 (average, 0.046; sd ± 0.032). All but one sample had a peak ratio of 0.11 or less. The peak ratios observed in the normal tissues suggest that the baseline methylated C-peak is about 5%-10% of the unmethylated peak in the tested samples. Therefore, we consider a sample as methylation positive if the peak ratio was >0.1. The observed small methylated C-peaks might represent the rarely methylated alleles in the normal samples or from the mismatch incorporation of the labeled ddNTP during the single base extension reaction. When we examined the methylation status in a panel of lung cancer cell lines having either methylated or unmethylated p16 INK4A promoter as confirmed by direct sequencing of the sodium bisulfite-treated and nonselectively amplified DNA templates, the sensitivity of MSBE was compatible to that of the standard MSP method (data not shown). Figure 3A is an example of p16 INK4A methylation status in primary lung cancer and non-tumor samples using the MSBE method. The relative ratios were 0.039 for the non-tumor lung, 0.199 for lung cancer no. 1, and 0.716 for lung cancer no. 2. In our hands, we observed that many tumor samples had the methylation-to-unmethylated peak ratios between 0.15-0.2, even though the tumor content was 40%-95%, suggesting the heterogeneity of the tumor cells. Figure 3B illustrates the detection of DNA methylation status at two different CpG islands in the p16 INK4A promoter region. In our hands, primers designed for each p16 INK4A methylation site worked robustly without the need for optimization as shown here for various primers at different methylation Titration of MSBE sensitivity ( Figure 2 ) and multiplex MSBE ( Figure 3B ). p16 INK4A PCR product from bisulfite-modified genomic DNA (gDNA) was cloned into TOPO cloning vector and mixed in different ratios as shown on the x-axis to represent the log ratio of the two input templates. These mixtures were used as a template for single base extension (SBE). The y-axis represents log values of the peak ratios from C (methylated) and T (unmethylated) gDNA after the MSBE assay. The primers used are described in Table 1 .
BENCHMARKS sites, and the MSBE assay could be used to detect multiple DNA methylation changes in different genomic loci without a loss in sensitivity.
Previously, methods such as methylation-sensitive single-nucleotide primer extension (Ms-SnuPE) have been proposed to detect gene methylation using a similar principle (4, 5) . However, these methods are often more complex, more subjective, or less adaptable for robust and systemic detection of DNA methylation status. For example, Ms-SNuPE requires the use of a radioisotope, two separate reactions for the SBE (each for radiolabeled ddC and ddT), and manual readout of the extension product. ElMaarri et al. (6) reported a method using a similarprinciple requiring high-performance liquid chromatography analysis for the detection of the single base-extended product. The most widely used MSP assay is very powerful but not quantitative and is difficult to apply to genomewide screening of candidate promoter sites of methylated genes. The MSBE assay described here could overcome these problems by providing highly robust and multisite evaluation of DNA methylation status for many different genes in a large number of samples.
In conclusion, despite the PCR bias against the methylated DNA strand for some genes after sodium bisulfite treatment, the highly quantitative nature of MSBE allows one to correlate relative ratio changes of the peaks corresponding to methylated and unmethylated strands as objective values for the determining the DNA methylation status of a sample at a specific site of interest. MSBE can also be used to simultaneously assess the methylation status at multiple CpG sites of interest with only minor modifications.
